Exhaled Breath Olfactory Signature of Pulmonary Arterial Hypertension

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 273 participants.

Also called NCT02782026

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 273 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02782026
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02782026. Non-randomized; no masking; primary purpose diagnostic. Start 2016-03-04 (actual); primary completion 2018-08-28 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Exhaled Breath Olfactory Signature of Pulmonary Arterial Hypertension
Acronym
SNOOPY2
Intervention (Device)
Exhaled Breath Olfactory Signature (Artificial Nose)
Lead sponsor
Assistance Publique - Hôpitaux de Paris (class: other)
Collaborator
Technion, Israel Institute of Technology (class: other)
Collaborator
Bayer (class: industry)

Record details

Record id
cardio:ct-nct02782026
Content hash
cc399ce38bf3ef2bcc9c4db5e02746efb4b29a5f4dc59546b76081365b3059a0